GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Shiller PE Ratio

Virbac (Virbac) Shiller PE Ratio : 25.99 (As of May. 12, 2024)


View and export this data going back to . Start your Free Trial

What is Virbac Shiller PE Ratio?

As of today (2024-05-12), Virbac's current share price is $354.75. Virbac's E10 for the fiscal year that ended in Dec22 was $13.65. Virbac's Shiller PE Ratio for today is 25.99.

The historical rank and industry rank for Virbac's Shiller PE Ratio or its related term are showing as below:

VRBCF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.56   Med: 34.2   Max: 71.72
Current: 45.87

During the past 13 years, Virbac's highest Shiller PE Ratio was 71.72. The lowest was 18.56. And the median was 34.20.

VRBCF's Shiller PE Ratio is ranked worse than
78.3% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs VRBCF: 45.87

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Virbac's adjusted earnings per share data of for the fiscal year that ended in Dec22 was $15.286. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $13.65 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


Virbac Shiller PE Ratio Historical Data

The historical data trend for Virbac's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Shiller PE Ratio Chart

Virbac Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.28 44.69 39.03 61.97 29.29

Virbac Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 61.97 - 29.29 -

Competitive Comparison of Virbac's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Virbac's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virbac's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Virbac's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Virbac's Shiller PE Ratio falls into.



Virbac Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Virbac's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=354.75/13.65
=25.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virbac's E10 for the fiscal year that ended in Dec22 is calculated as:

For example, Virbac's adjusted earnings per share data for the fiscal year that ended in Dec22 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec22 (Change)*Current CPI (Dec22)
=15.286/114.1600*114.1600
=15.286

Current CPI (Dec22) = 114.1600.

Virbac Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 9.836 99.800 11.251
201412 9.297 99.860 10.628
201512 1.220 100.040 1.392
201612 4.335 100.650 4.917
201712 -0.367 101.850 -0.411
201812 2.719 103.470 3.000
201912 6.789 104.980 7.383
202012 19.611 104.960 21.330
202112 15.119 107.850 16.004
202212 15.286 114.160 15.286

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Virbac  (OTCPK:VRBCF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Virbac Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Virbac's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac (Virbac) Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (Virbac) Headlines

From GuruFocus

Full Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Virbac SA SFAF Meeting Transcript

By GuruFocus Research 03-08-2024

Full Year 2018 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024